OctoPlus has entered into a pharmaceutical manufacturing contract with a French biotechnology company.
Subscribe to our email newsletter
OctoPlus said that the undisclosed contract value will make a material contribution to its’ annual revenues.
As per the contract terms, OctoPlus is expected to perform clinical manufacturing for the client’s product candidate.
OctoPlus provides formulation development and clinical material manufacturing services to biotech and pharmaceutical companies worldwide.
In addition OctoPlus offers its clients drug delivery technologies for the development of controlled release versions of existing or new drugs.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.